Gene and cell therapies hold incredible promise, but their success relies on public trust and understanding.
Building on 20 years of work in public and researcher community engagement, the European Consortium for Communicating Gene and Cell Therapy Information (EuroGCT) aims to ensure that everyone has access to reliable and understandable information on these innovative treatments – including the underlying science, their ethical and social impact, and how they are developed and regulated.
EuroGCT brings together 47 European partner organisations and institutions to provide multilingual, independent, expert-reviewed resources, to help European stakeholders make sense of gene and cell therapies.
